Latest News
Dunas Capital, an independent real estate and asset management platform, has invested 100% of the €104 million raised by its Dunas Aviation I FCR and Dunas Capital Aviation SCR vehicles, with which it has created a diversified portfolio of 12 commercial aircraft with a value of approximately USD400 million.
This is the first fund focused on this type of asset class that has been ever marketed in Spain.
Dunas Capital launched these private capital vehicles in January 2020, before the Covid-19 crisis, with the objective of investing in commercial aircraft on long-term lease to first tier airlines. The fund’s investor
Konsileo, a commercial insurance broker and risk management adviser, has completed a £4.7 million Series A funding round led by growth tech VC Committed Capital.
Committed Capital first invested in Konsileo in 2018, and provided £3.23m of the current funding round. New investors include a £900,000 investment from ACF Investors, a UK venture capital fund and angel investors.
Konsileo has developed a proprietary broking platform with built-in compliance checks, and policy administration that frees brokers from unnecessary repetitive tasks and
facilitates exceptional risk capture and insight and cross-firm collaboration.
Banor Capital, the €1.7 billion London-based investment management firm, has renamed the Banor SICAV North America Long Short Equity Fund to reflect the fund’s increasing focus on companies active in the field of energy transition, with a particular emphasis on the battery value chain.
It is now named the Banor SICAV Volta Long Short Equity Fund.
The move came in response to increasing demand from institutional investors for exposure to the energy transition theme, and Banor Capital selected Westbeck Capital LLP to take over as adviser to the fund.
The firm was chosen because of its significant long/short
Apex Group Ltd (Apex) has acquired Darwin Depositary Services (Darwin), a provider of depositary services to Alternative Investment Funds.
Darwin, a leading independent AIFMD depositary in mainland Europe, provides services to clients based in the Netherlands and outside the EU, including hedge funds, real estate, debt and private equity funds as well as funds investing in infrastructure and renewable energy.
Apex Group currently delivers depositary services through subsidiary European Depositary Bank (EDB) in Luxembourg, Ireland, UK and Malta; the addition of the Darwin business will add €4.5bn of Assets under Depositary to the Group (as at 31 May 2022),
Bluewater-backed Varel Energy Solutions (VES) as acquired Sledgehammer Oil Tools (Sledgehammer), an international leader in the supply of oilfield casing, cementing and completion products.
European private equity house Triton’s €5.2 billion Fund V is to acquire OCU Group, the holding company of O’Connor Utilities and Instalcom, a UK multi-utility services specialist operating within regulated infrastructure.
NPIF Maven Equity Finance, managed by Maven Capital Partners (Maven) and part of the Northern Powerhouse Investment Fund (NPIF), has invested £2 million in Ideiio, a Salford based software as a service (SaaS) cyber security business.
Ideiio specialises in Identity Governance and Administration (IGA). Its software enables organisations to manage control of access rights across the entire business and automate key functions such as compliance and audit reporting. The majority of competitor IGA platforms in the market focus on larger enterprise clients, whereas Ideiio’s technology is targeted at the under-served mid-market. It provides a valuable solution which helps its customers
Biosynth Carbosynth (Biosynth), a supplier of critical products and services to the life sciences industry, has acquired Pepscan, an expert provider of peptide-based products & services and portfolio company of the KKR Health Care Growth fund.
Biosynth’s ability to deliver chemical manufacturing services “from the first idea to the finished product” is now matched in peptides, with Pepscan’s expertise in both lead discovery & optimisation and GMP production combining with the capabilities of vivitide, the US peptide specialists, which joined Biosynth in March.
The two companies will form Biosynth’s new Peptide division, with broad capabilities and offering to the pharma
French speciality pharmaceutical company, Juvisé Pharmaceuticals has completed a transaction with AbbVie, regarding the acquisition of the worldwide commercial rights of Pylera.
Financial details of the transaction have not been disclosed.
A €400 million financing was raised with Société Générale, Juvisé Pharmaceuticals historic and lead bank, supporting the funding of this latest acquisition together with the refinancing of its existing debt. Lazard and Latham & Watkins served as financial and legal advisors for Juvisé Pharmaceuticals, whereas White & Case served as legal advisors for Société Générale.
Investec has appointed Kate Gribbon as head of financial sponsor coverage for private equity, growth equity and venture capital.
In the role, Gribbon will be responsible for sponsor coverage across Investec’s suite of advisory and debt solutions spanning private company fundraising, M&A and IPOs, leveraged finance and fund level finance.
Gribbon joined Investec in 2020 to jointly lead the bank’s Private Company Fundraising team, advising ambitious, fast growing companies seeking growth capital. Prior to joining Investec, Gribbon spent 13 years advising in the M&A mid-market.
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
